SARS-CoV-2 RNA and antibodies in tear fluid

Background/aims SARS-CoV-2 is highly contagious. More evidence concerning extrapulmonary transmission routes such as the eyes is urgently needed. Although the humoral immune response is important in the viral containment, the local response in tears has not yet been studied. The aim of our study was twofold: to assess the prevalence of both SARS-CoV-2 RNA and antibodies in tear fluid. Methods In a first series, nasopharyngeal sampling and tear sampling by Schirmer test strips were performed in 26 acutely ill patients with COVID-19 to assess the presence of SARS-CoV-2 RNA by reverse transcription PCR. In a second series, IgG and IgA responses to SARS-CoV-2 spike protein in serum and tear fluid of convalescent individuals (n=22) were compared with control individuals (n=15) by ELISA. Results SARS-CoV-2 RNA was detected in tears of 7/26 (26.9%) patients with COVID-19. None of them had ocular symptoms. Convalescent individuals displayed a significant higher ratio of IgG (p<0.0001) and IgA (p=0.0068) in tears compared with control individuals. A sensitivity of 77.3% and specificity of 93.3% was observed for IgG, and 59.1% and 100% for IgA. Conclusions Our results demonstrate the presence of SARS-CoV-2 RNA and a local IgG and IgA immune response in tear fluid. These data confirm the possibility of SARS-CoV-2 transmission through tear fluid and the importance of the eye as a first defence against SARS-CoV-2, indicating the potential of tears as a non-invasive surrogate for serum in monitoring the host immune response.

[1]  Ming Yan,et al.  Detection of SARS-CoV-2 in Simultaneously Collected Tear and Throat Swab Samples from the Patients with 2019- new SARS-CoV-2 Infection Disease: A Single Center Cross-sectional Study , 2021, Ophthalmic epidemiology.

[2]  A. Moreno,et al.  Characteristics of Ocular Findings of Patients with Coronavirus Disease , 2020, International Journal of Advanced Engineering Research and Science.

[3]  A. Aguzzi,et al.  Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[4]  A. Gingras,et al.  Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients , 2020, Science Immunology.

[5]  Daniel L. Chao,et al.  Potential of Ocular Transmission of SARS-CoV-2: A Review , 2020, Vision.

[6]  Sumit Kumar,et al.  Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19 , 2020, Ophthalmology.

[7]  J. García-Feijóo,et al.  Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review , 2020, Advances in Therapy.

[8]  Huimin Yu,et al.  SARS-CoV-2 on the ocular surface: is it truly a novel transmission route? , 2020, British Journal of Ophthalmology.

[9]  R. Vunnam,et al.  Transmission of SARS-CoV-2: an update of current literature , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  A. Meduri,et al.  Symptomatology in head and neck district in coronavirus disease (COVID-19): A possible neuroinvasive action of SARS-CoV-2 , 2020, American Journal of Otolaryngology.

[11]  C. Guarneri,et al.  Ocular surface manifestation of COVID-19 and tear film analysis , 2020, Scientific Reports.

[12]  E. Duh,et al.  ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection , 2020, The Ocular Surface.

[13]  M. Lako,et al.  Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface , 2020, The Ocular Surface.

[14]  O. Rötzschke,et al.  The role of IgA in COVID-19 , 2020, Brain, Behavior, and Immunity.

[15]  M. Coroneo.  The eye as the discrete but defensible portal of coronavirus infection , 2020, The Ocular Surface.

[16]  S. Safi,et al.  Detection of severe acute respiratory syndrome Coronavirus-2 in the tears of patients with Coronavirus disease 2019 , 2020, Eye.

[17]  Malik Peiris,et al.  Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures , 2020, The Lancet Respiratory Medicine.

[18]  Kaili Wu,et al.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China , 2020, JAMA ophthalmology.

[19]  R. Agrawal,et al.  Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients , 2020, Ophthalmology.

[20]  Chuan Qin,et al.  Reinfection could not occur in SARS-CoV-2 infected rhesus macaques , 2020 .

[21]  J. Tong,et al.  Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection , 2020, Journal of medical virology.

[22]  Zhiqi Chen,et al.  Ocular Dectection of SARS-CoV-2 in 114 Cases of COVID-19 Pneumonia in Wuhan, China: An Observational Study , 2020 .

[23]  D. Ting,et al.  Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear , 2020, British Journal of Ophthalmology.

[24]  Cheng-wei Lu,et al.  2019-nCoV transmission through the ocular surface must not be ignored , 2020, The Lancet.

[25]  Alain Le Coupanec,et al.  Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? , 2019, Viruses.

[26]  Alexis M. Kalergis,et al.  Neurologic Alterations Due to Respiratory Virus Infections , 2018, Front. Cell. Neurosci..

[27]  P. Verhaert,et al.  Bottom–up protein identifications from microliter quantities of individual human tear samples. Important steps towards clinical relevance. , 2015 .

[28]  S. Brendle,et al.  Antibody detection in tear samples as a surrogate to monitor host immunity against papillomavirus infections in vaccinated and naturally infected hosts. , 2014, The Journal of general virology.

[29]  L. Tong,et al.  Patient Acceptability of Tear Collection in the Primary Healthcare Setting , 2014, Optometry and vision science : official publication of the American Academy of Optometry.

[30]  T. Barisani-Asenbauer,et al.  Cytomegalovirus antibodies in tear fluid of patients with retinitis , 2006, Archives of Virology.

[31]  Xinchun Chen,et al.  Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome , 2004, The Journal of infectious diseases.

[32]  M. Friedman.  Antibodies in human tears during and after infection. , 1990, Survey of ophthalmology.

[33]  P. Sibony,et al.  Viral antibodies in normal tears. , 1988, Investigative ophthalmology & visual science.

[34]  P. Khaw,et al.  Tear and serum antibody levels in ocular herpetic infection: diagnostic precision of secretory IgA. , 1986, The British journal of ophthalmology.

[35]  J. Ebersole,et al.  Immunoglobulin A antibody levels in human tears, saliva, and serum , 1982, Infection and immunity.

[36]  D. Sen,et al.  Immunoglobulin concentrations in human tears in ocular diseases. , 1979, The British journal of ophthalmology.

[37]  T. Tomasi,et al.  THE SELECTIVE OCCURENCE OF GAMMA-1A GLOBULINS IN CERTAIN BODY FLUIDS. , 1963, The Journal of clinical investigation.